Skip to main content

FDA Approvals

FDA Approvals, In the News
FDA Approves Empliciti, a New Immune-Stimulating Therapy to Treat Multiple Myeloma
Read More
FDA Approvals, In the News
FDA Approves Ninlaro, New Oral Medication to Treat Multiple Myeloma
Read More
FDA Approvals, In the News
FDA Approves Darzalex for Patients with Previously Treated Multiple Myeloma
Read More
FDA Approvals, In the News
FDA Approves Praxbind, the First Reversal Agent for the Anticoagulant Pradaxa
Read More
FDA Approvals
Vyvanse (Lisdexamfetamine Dimesylate): First FDA-Approved Drug for the Treatment of Adults with Binge-Eating Disorder
Read More
FDA Approvals
Ibrance (Palbociclib): First CDK4 and CDK6 Inhibitor FDA Approved for the Treatment of Postmenopausal Women with Metastatic Breast Cancer
Read More
FDA Approvals
Lemtrada (Alemtuzumab) a New Treatment Option Approved by the FDA for the Treatment of Relapsing Forms of Multiple Sclerosis
Loretta Fala
Read More
FDA Approvals
Farydak (Panobinostat): First HDAC Inhibitor Approved for the Treatment of Patients with Relapsed Multiple Myeloma
Lisa A. Raedler, PhD, RPh
Read More
FDA Approvals
Brintellix (Vortioxetine) Receives FDA Approval for the Treatment of Major Depressive Disorder
Loretta Fala
Read More
FDA Approvals
Injectafer (Ferric Carboxymaltose Injection) Receives FDA Approval for the Treatment of Iron-Deficiency Anemia
Loretta Fala
Read More
Page 19 of 21
Results 181 - 190 of 205